ARCUS BIOSCIENCES INC (RCUS)
US03969F1093 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 185.00M | 127.00M | 206.00M | 147.90M | 173.40M | |||
| Marketable Securities | 810.00M | 632.00M | 803.00M | 351.40M | 555.20M | |||
| Receivables | 40.00M | 42.00M | 39.00M | 746.80M | 1.70M | |||
| Other Current Assets | 29.00M | 30.00M | 19.00M | 15.60M | 5.50M | |||
| Total Current Assets | 1.06B | 831.00M | 1.07B | 1.26B | 735.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 51.00M | 143.00M | 135.00M | 137.40M | 23.60M | |||
| Investments And Advances | 100.00M | 107.00M | 129.00M | 182.00M | 6.40M | |||
| Other Non-Current Assets | 78.00M | 14.00M | 14.00M | 10.70M | 6.40M | |||
| Total Non-Current Assets | 229.00M | 264.00M | 278.00M | 330.10M | 36.50M | |||
| TOTAL ASSETS | 1.29B | 1.09B | 1.34B | 1.59B | 772.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 64.00M | 76.00M | 76.00M | 52.00M | 30.70M | |||
| Accounts Payable | 16.00M | 17.00M | 20.00M | 10.30M | 15.70M | |||
| Other Current Liabilities | 124.00M | 91.00M | 97.00M | 103.90M | 75.30M | |||
| Total Current Liabilities | 204.00M | 184.00M | 193.00M | 166.10M | 121.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 382.00M | 449.00M | 495.00M | 584.40M | 148.30M | |||
| Total Non-Current Liabilities | 382.00M | 449.00M | 495.00M | 584.30M | 148.30M | |||
| TOTAL LIABILITIES | 586.00M | 633.00M | 688.00M | 750.40M | 270.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -853.00M | -849.00M | -542.00M | -275.40M | -328.20M | |||
| Additional Paid In Capital | N/A | N/A | N/A | 1.12B | 830.40M | |||
| Common Shares | 1.56B | 1.31B | 1.21B | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.00M | 0.00 | -7.00M | -1.30M | 0.00 | |||
| Shares Outstanding | 90.90M | 75.50M | 72.90M | 70.80M | 65.10M | |||
| Tangible Book Value per Share | 7.78 | 6.12 | 9.01 | 11.89 | 7.72 | |||
| Total Shareholders' Equity | 707.00M | 462.00M | 657.00M | 841.50M | 502.30M | |||
| TOTAL LIABILITIES AND EQUITY | 1.29B | 1.09B | 1.34B | 1.59B | 772.30M | |||
| Statistics | ||||||||
| Current Ratio | 5.22 | 4.52 | 5.53 | 7.60 | 6.05 | |||
| Return On Assets (ROA) | -17.87% | -28.04% | -19.85% | 3.32% | -15.91% | |||
| Return On Equity (ROE) | -32.67% | -66.45% | -40.64% | 6.27% | -24.47% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 3.00% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 4.62% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 4.62% | N/A | |||
All data in USD